Myriad Genetics and Lumea Inc. partner to integrate molecular diagnostics into Lumea's digital pathology platform, enhancing cancer care efficiency. Myriad Genetics and Lumea Inc. have announced a ...

MIAMI, FL / ACCESS Newswire / December 17, 2025 / KIFFIK Biomedical announced today the successful close of its Series A financing, completed ahead of schedule and significantly oversubscribed. The ...

As we look ahead to 2026, we are continuing to execute on our strategy with purpose and momentum to create value for all our stakeholders.” OTI’s rapid self-test for CT/NG is built on the Sherlock ...

Neither a one-meter drop nor constant motion and vibration prevent the device from completing tests with near 100% accuracy, proving its utility at Point of Need™ in virtually any environment ALAMEDA, ...

The Australian patent represents the first patent granted for the Company's new point-of-care testing platform ...

Joint Genome Institute Demonstrates Feasibility of Alveo Technologies' Portable Molecular Testing Platform for Wastewater Pathogen Surveillance Provided by PR Newswire Oct 23, 2025, 5:00:00 AM Joint ...

High Efficiency means low-cost, easy-to-use molecular testing under $20 per test with no sample preparation required. 3EO announces the availability of no charge ...

The ongoing outbreak in cattle increases the risk of further mutations to spread efficiently in humans highlighting the need for an accurate decentralized testing ecosystem ALAMEDA, Calif., July 18, ...

OraSure TechnologiesOSUR recently announced that it submitted two applications to the FDA seeking approval for its two new at ...

Technologies submitted two separate applications at the end of 2025 to the U.S. Food and Drug Administration for clearance of its ...